< PreviousGENERAL INFORMATION60 Brain Teasers 1 2 3 4 567 8 9 10 11 12 1314 Down:Across: 1.Calouste ____________, amassed thousands of works of art, able to view at a museum 2.Lisbon is Europe's ____________ capital city 3.Portuguese national dish dating back to the 16th century 4.Portugal is famous for its _________ sidewalks 5.Architectural style found in various buildings 6.in 1755, this destroyed Lisbon 7.Best way to traverse the hilly neighbourhood 8.Small versions of dishes, usually as starters9.Describing Portugals weather 10.The Belem Tower used to be a _________11.Music style dating back 200 years 12.Ornamental design covering the walls 13.Portugal is the highest producer of _____ 13.Lisbon is home to many _________ 14.Lisbon is between ______ hills To check your answers, scan the QR code!FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202361 Can you find the 5 mistakes in the picture on the right? NXYOWQOEUGFDXJGPTBGKXNQIXBLZMH PNBEVZSNJVWKOQMUCOIFXWWQJOGSQS TIUNSNHEQYDWPYFEQWMSWGTUDAFMDY VCZLEXKFPEBTUFWOHHMXILGWQGCURZ EYLJIXQPXINRPLXDHSUNGYUTKDOBAT MUOBZNKTWGDBHZULWFNWJNEEVTKMAD NFDXQNFTSEZEGZPQANORHFDMTSKDQN SVWDLFNEBCOPMKUGHZLBKCDLNRKBPW GHUHPWWECWTAPIKPAFOXGIIQCOBAHE SVFMOILLTTHABAOGPIGSAXMXYANBWK TLXYGDJTEAIQUBDLSXYYKLNQVDPLIW MRGYWEXCXNHOJRGROILYTFHZDHNBNL CESEWUDFPOXZNNQXVGMVNXXYZQLMET PLJPNNIXCCQLASZHOKYIAWHWRDELOC JXIAXYSXOQEPMJPQCWFDCCTIXGNFCV KSQNVAXUUDGUAEDWMRUJWRCGHPKDSC PGCOUMEITIARXRPMLCHKXHOIUCYHKA THESIAAGBAYQIHAMYEDLHCMBNGFTWC XEZOTWVRRGKLQHRSJCJSDFBDIOHSIN RTFCLPKWENXILFCMILOHIFJDAOLBDS DNBOHDATAOIEARMUQTULQJVITXLOER ROIMDJUIKSHTXPIDWLEOOMMXKBROGB UMOIEIEZLTVGIYHKLRELXGSCSWVKGY QTFAEGIXJIWWNBUHNRIPTUYKCHDSLY MUILWFYXKCMFEIEEWRQSBQHKFIPAAA JXLDKUHLTSOLYZRDQEVAZEDKPPQBXO ETMRMGVOBTPDTKJHDDJJPHZSFPFKEW YSSQIBWCUCPGDZDJYAJNKQAGBLLIQV GATNPUOKYKUORDHLYMEOEGJBEBROGQ AMAKLXYJJXGLSFHXCYULDBIBNFFWJR EpidemiologyMicrobiologyVaccinologyDiagnostics NosocomialImmunologyInfectionsParasite OutbreakMycologyLymeBiofilmsSCIENTIFIC PROGRAMME62FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202363 ADDENDUM Scientific Programme with Session DetailsSCIENTIFIC PROGRAMME64 Scientific Programme Saturday, 23 April 2022 ID SY00108:30 - 10:30Hall C Symposium Infections in patients receiving new immunomodulatory therapies ChairsOliver A. Cornely (Cologne, Germany) Carlota Gudiol (Barcelona, Spain) S000108:30Patients receiving immune check-point inhibitors Gil Redelman-Sidi (New York, United States) S000209:00Patients receiving CAR-T therapy Andrea Henden (Herston, Australia) S000309:30Non-neutropenic infection associated risk in patients with haematological malignancies Monica Slavin (Melbourne, Australia) S000410:00Patients receiving therapy for systemic or organ- specific autoimmune diseases Mario Fernandez Ruiz (Madrid, Spain) ID SY00208:30 - 10:30Hall G Symposium Fungal infections from head to toe ChairsAnuradha Chowdhary (Delhi, India) Emmanuel Roilides (Thessaloniki, Greece) S000508:30Emerging treatment failure in dermatophytosis: genotyping and resistance testing of the Trichophyton mentagrophytes species complex Philipp Bosshard (Zurich, Switzerland) S000609:00Update on Tinea capitis: epidemiology, symptoms and treatment Pietro Nenoff (Mölbis, Germany) S000709:30Update on diagnosis and treatment of recurrent vulvovaginal candidiasis Riina Richardson (Manchester, United Kingdom) S000810:00The role of Malassezia in health and disease Ditte Marie Lindhardt Saunte (Roskilde, Denmark) Co-organised with: ESCMID Fungal Infection Study Group (EFISG) PH SY00308:30 - 10:30Hall I Symposium Genomics underpin the clinical and public health management of tuberculosis ChairsSebastien Gagneux (Basel, Switzerland) Robyn Lee (Toronto, Canada) S000908:30Understanding TB pathogenicity and host interactions using genomic approaches Stefan Niemann (Borstel, Germany) S001009:00Genomics in the diagnosis of drug resistance in TB Paolo Miotto (Milano, Italy) S001109:30Integrating genomics into TB management in an African setting Yonas Kassahun (Addis Ababa, Ethiopia) S001210:00New tools for genomic prediction and mapping of resistance in TB Timothy Walker (Ho Chi Minh City, Vietnam) ID CM SY00408:30 - 10:30Hall L Symposium Challenges and opportunities in CM/ID training and practice ChairsEmmanuelle Cambau (Paris, France) Valentijn Schweitzer (Utrecht, Netherlands) S001308:30How to excel and become a leader in CM, ID or IC? Truls Michael Leegaard (Lørenskog, Norway) S001409:00Developing effective communication skills: social media and networking Muge Cevik (Edinburgh, United Kingdom) S001509:30Practising Clinical Microbiology in low-resource settings Makeda Semret (Montreal, Canada) S001610:00Practising Infectious Diseases in low-resource settings Sipho Kenneth Dlamini (Cape Town, South Africa) Co-organised with: ESCMID Professional Affairs Subcommittee (PAS), Trainee Association of ESCMID (TAE) Presentations in light grey were not registered at the time of publishing.FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202365 ID SY00508:30 - 10:30Hall P Symposium New insights into phages: current challenges and future developments ChairsJoana Azeredo (Braga, Portugal) Jean-Paul Pirnay (Brussels, Belgium) S001708:30Preparation standards for personalised phage therapy Kiljunen Saija (Helsinki, Finland) S001809:00Immune responses and phage: how phage pharmacokinetics is shaped by immunological factors Krystyna Dabrowska (Warsaw, Poland) S001909:30Clinical trials with phages: design challenges and regulatory issues Shawna Mccallin (Schlieren, Switzerland) S002010:00Clinical evidence for the efficacy of phages (so far) Tristan Ferry (Lyon, France) Co-organised with: ESCMID Study Group for Non- traditional Antibacterial Therapy (ESGNTA) CM EW00608:30 - 11:30Hall A Educational Workshop EUCAST Educational Workshop ChairsAlasdair P. MacGowan (Bristol, United Kingdom) Arjana Tambic Andrasevic (Zagreb, Croatia) W002108:30EUCAST Update Christian Giske (Stockholm, Sweden) W002209:00Putting certainty into antimicrobial susceptibility testing Gunnar Kahlmeter (Växjö, Sweden) W002309:30PK/PD breakpoints in the EUCAST breakpoint tables Shampa Das (Liverpool, United Kingdom) W002410:00Revising aminopenicillin breakpoints John D. Turnidge (Hawthorn, Australia) W002510:30Screening and testing for antifungal resistance Maiken Arendrup (Copenhagen, Denmark) Co-organised with: EUCAST Steering Committee, ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) IC EW00708:30 - 10:30Hall E Educational Workshop Advances in Clostridioides difficile infection outbreak prevention and control ChairsSarah Tschudin Sutter (Basel, Switzerland) Lutz Von Müller (Coesfeld, Germany) W002608:30Is there a role for ribotyping in the WGS era? Windy Tanner (New Haven, United States) W002709:00Any Clostridium lurking in your patient room? The role of the community environment in C. difficile outbreaks Sandra Janezic (Maribor, Slovenia) W002809:30Going with the FLO: frontline ownership is crucial for C. difficile outbreak prevention and management Gianluca Ianiro (Rome, Italy) Co-organised with: ESCMID Study Group for Clostridioides difficile (ESGCD), ESCMID Study Group for Nosocomial Infections (ESGNI) PH EW00808:30 - 10:30Hall H Educational Workshop New perspectives on schistosomiasis in Europe ChairsAndreas Neumayr (Basel, Switzerland) Lisette Van Lieshout (Leiden, Netherlands) W002908:30Gaps in managing schistosomaisis in Europe Eyrun Kjetland (Oslo, Norway) W003009:00One Health perspective on schistosomiasis: prevalence and distribution of schistosomiasis in a multi-host system Joanne Webster (Hatfield, United Kingdom) W003109:30The toolkit for diagnosis and morbidity assessment of schistosomiasis: lab and beyond Francesca Tamarozzi (Negrar, Italy) Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) ID EW00908:30 - 10:30Hall M Educational Workshop Novel predictive and diagnostic tools in severe viral and bacterial infections ChairsBarbara C. Kahl (Münster, Germany) Mi-Na Kim (Seoul, Korea, Republic of) W003208:30Living colours of infection and inflammation Olivier Gheysens (Leuven, Belgium) Saturday, 23 April 2022SCIENTIFIC PROGRAMME66 W003309:00Hypercytokinaemia in critically ill COVID-19 as indicator of cell death and secondary bacterial infections Srikanth Mairpady Shambat (Zurich, Switzerland) W003409:30Specific clinical phenotypes of necrotising soft- tissue infection predicted by discriminatory biomarker signatures Anna Norrby-Teglund (Stockholm, Sweden) ID EW01008:30 - 10:30Hall Q Educational Workshop Understanding COVID-19 lung disease ChairsAdrian John Brink (Cape Town, South Africa) Veroniek Saegeman (Sint-Niklaas, Belgium) W003508:30Infectious disease and public health perspective Raquel Duarte (Porto, Portugal) W003609:00ICU perspective Sascha David (Zurich, Switzerland) W003709:30Pathologist`s perspective Domitille Callon (Reims, France) Co-organised with: ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR), Spanish Society of Forensic Pathologists (SEPAF), Spanish Society of Pathologists (SEAP) OS01108:30 - 10:30Hall B 2-Hour Oral Session New insights on typing: viewing the genome above and below the infrared spectrum ChairsNatacha Couto (Bath, United Kingdom) Mario Ramirez (Lisbon, Portugal) O0038Early identification of an outbreak involving OXA-48 producing Klebsiella pneumoniae using Fourier transform infrared (FT-IR) spectroscopy typing C. Pitart* (Barcelona, Spain), Y. Zboromyrska, J. Bosch, E. Rubio, M. Piquet, B. Torralbo, I. Fortes, S. Valls, L. Rodriguez, G. Santana, A. Del Río, J.A. Martinez, A. Vilella, A. Soriano, C. Casals-Pascual, I. Roca, J. Vila O0039Development and evaluation of a new typing system for Treponema pallidum F. González-Candelas* (Paterna, Spain), M. Diaz-Pla, P. Pospíšilová, D. Šmajs, T. Kawahata, P.P. Bosshard, K. Nieselt, N. Arora, L. Giacani O0040Comparison of a novel whole genome multilocus sequence typing (wgMLST) schema forStreptococcus pyogeneswith other typing methods A. Friães* (Lisbon, Portugal), R. Mamede, M. Ferreira, J. Melo-Cristino, M. Ramirez O0041Turning ATR FT-IR spectroscopy into an easy, quick and reproducibleKlebsiella pneumoniae typing method Â. Novais* (Porto, Portugal), A.B. Gonçalves, T.G. Ribeiro, A.R. Freitas, G. Mendéz, L. Mancera, A. Read, V. Alves, L. López-Cerero, J. Rodríguez- Baño, Á. Pascual, L. Peixe O0042Rapid Clostridiodes difficileribotyping based on MALDI-TOF MS and machine learning A. Candela* (A Coruña, Spain), D. Rodriguez-Temporal, M.J. Arroyo, M. Marin, A. Martin, L. Jimenez-Navarro, L. Alcala, G. Mendez, P. Muñoz, L. Mancera, B. Rodriguez-Sanchez O0043Evaluation of Fourier-tansform infrared spectroscopy as a typing method for vancomycin-resistant Enterococcus faeciumisolates J. Liese* (Tübingen, Germany), S. Wolf, F. Melcharick, B. Bader, S. Peter O0044Escherichia marmotae: ayet unrecognised Escherichia species and its impact for zoonotic and antimicrobial resistance transmission U. Binsker* (Berlin, Germany), A.K. Gadicherla, A. Käsbohrer, J.A. Hammerl O0045Phylogenomics of Pseudomonas aeruginosa isolated from mechanically ventilated patients in European intensive care units M. Berkell* (Antwerp, Belgium), T.E. Van Der Schalk, D.E. Tabor, B.B. Xavier, C. Recanatini, L. Timbermont, P. Tedder, C. Lammens, A. Digiandomenico, B. François, H. Jafari, J. Kluytmans, A. Ruzin, J. Chastre, H. Goossens, M.T. Esser, S. Malhotra-Kumar O0046Validation of an optimised whole genome sequencing workflow for the detection of virulence factors and resistance to methicillinof Staphylococcus aureus strains in a national reference laboratory C. Kolenda* (Lyon, France), P. Martins-Simoes, C. Dupieux-Chabert, A.G. Ranc, B. Youenou, L. Beraud, C. Ginevra, E. Jeanne, F. Laurent, F. Vandenesch, A. Tristan O0047Within host genetic variation in Neisseria gonorrhoeae over the course of infection J. De Korne-Elenbaas* (Amsterdam, Netherlands), S.M. Bruisten, H.C.J. De Vries, A.P. Van Dam OS01208:30 - 10:30Hall J 2-Hour Oral Session COVID-19 diagnostics: new and newer ChairsPetar Velikov (Sofia, Bulgaria) Snjezana Zidovec Lepej (Zagreb, Croatia) O0048Is an increasing occurrence of SARS-CoV-2 N gene dropout variants in a frequently employed multiplex RT-PCR assay indicating a selection advantage of a new variant? D.F. Hilti* (Buchs, Switzerland), F. Wehrli, A. Roditscheff, M. Risch, F. Rudolf, L. Lorenz, A. Egli, T. Bodmer, N. Wohlwend Saturday, 23 April 2022FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202367 O0049Performance of self-testing with SARS-CoV-2 antigen rapid diagnostic test in healthcare workers: a multi-centre study V. Zwart* (Breda, Netherlands), N. Van Der Moeren, J.L. Murk, J. Stohr, J. Kluytmans, W. Van Den Bijllaardt O0050Use of artificial intelligence on rapid COVID-19 diagnosis using real-time polymerase chain reaction data B. Baddal* (Nicosia, Cyprus), T. Sanlidag, E. Özbilge O0051SARS-CoV-2 detection in saliva samples from children using RT-PCR assays: a systematic review and meta-analysis of accuracy G. Menchinelli* (Rome, Italy), G. De Angelis, A. Grossi, B. Posteraro, M. Sanguinetti O0052Multi-centre clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing M. Fernández-Huerta* (Pamplona, Spain), P. Salmerón, Y. Hernández-Hermida, J. Niubó, L. Calatayud, M.A. Domínguez, T. Pumarola, C. Ardanuy, C. Andrés, A. Antón, J. Càmara O0053A 29-mRNA host response assay accurately identifies patients with COVID-19, detects bacterial co- and superinfections and predicts severity of illness at clinical presentation: a prospective multi-centre trial W. Bauer* (Berlin, Germany), S. Glaeser, J. Borchardt, A. Peric, J. Bialas, N. Galtung, O.L.I.E.S. Liesenfeld, L. Sun, L. May, S. Ott, S. Vesenbeckh O0054Clinical performance of direct RT-PCR testing of raw saliva for detection of SARS-CoV-2 in symptomatic and asymptomatic individuals N. Lucca* (Galway, Ireland), R. Castillo-Bravo, L. Lai, K. Marlborough, G. Brychkova, B. Smyth, P. Mckeown, J. Feenstra, C. Ulekleiv, M. Gandhi, C. Spillane O0055Longitudinal patterns of exhaled SARS-CoV-2 viral load collected by face-mask sampling and its relation to nasopharyngeal sampling viral load, clinical symptoms and household transmission in infected healthcare workers D. Pan* (Leicester, United Kingdom), C.M. Williams, J. Decker, E. Fletcher, S. Sze, S. Assadi, R. Haigh, B. Saleem, J. Nazareth, T. Clark, N.J. Garton, M. Pareek, M.R. Barer O0056Saliva as a sample type for cost-effective and scalable SARS-CoV-2 testing A. Wyllie* (New Haven, United States), O. Allicock, D. Yolda-Carr, C. Vogels, A. Watkins, M. Petrone, N. Grubaugh O0057The role of subgenomic RNA in causing inconclusive results from RT-PCR tests for COVID-19 N. Toppings* (Calgary, Canada), L. Oberding, Y.C. Lin, D. Evans, D. Pillai OS01308:30 - 10:30Hall K 2-Hour Oral Session Advances in prevention of urinary catheter and central line- associated bloodstream infections ChairsLisa Hall (Herston, Australia) Clare Rock (Baltimore, United States) O0058Impact of a national intervention on CLABSI and non-CLABSI rates in Israeli medical-surgical ICUs D. Ben-David* (Holon, Israel), A. Vaturi, E. Temkin, L. Wullfhart, E. Solter, Y. Carmeli, M. Schwaber O0059Combating multidrug-resistant catheter-related infections with cold plasma technology Z. Dor* (Ariel, Israel), Y. Bormashenko, J. Giller, J. Moran-Gilad, E. Bormashenko, S. Navon-Venezia O0060The accuracy of fully-automated surveillance algorithms for central venous catheter-related bloodstream infections in hospitalised patients S.D. Van Der Werff* (Stockholm, Sweden), M. Karmefors Idvall, H. Tanushi, P. Nauclér O0061Staphylococcus aureus nasal carriage and Staphylococcus aureusbloodstream infection among conventional haemodialysis patients in Thailand: a prospective multi-centre cohort study W. Nasomsong* (Bangkok, Thailand), T. Techasuphaboon, V. Vasiksin, N. Varothai, N. Rak Nai Sil O0062The impact of COVID-19 on central line- associated bloodstream infections (CLABSI) and device utilisation ratio (DUR) at a large healthcare system in Miami, FL A. Jimenez* (Miami, United States), A. Garcia, K. Sposato, J. Cardozo, O. Orozco, M. Ruiz, R. Mcdade, R. Williams, G. Sidimirova, J. Dobson, D. Roberts, K. Manzanillo, G. Rosello, R. Rosa, L. Abbo O0063Antiseptic barrier caps in central line-associated bloodstream infections: a systematic review and meta-analysis M. Leal Dos Santos* (Lisbon, Portugal), S. Tejada, R. Martínez-Reviejo, Y. Peña-Lopez, S. Blot, E. Alp, J. Rello O0064Surveillance programme for bloodstream infections in long-term central venous catheters in outpatient chemotherapy services D. Assis* (São Paulo, Brazil), M. Freire, F. Carlesse, P.C.P. Germano, J.M. Viroli, A.C. Turdo, B.Q. Rodrigues, A.L.P. Maciel, M.M. Viu, J.D.C. Belizario, P. Goncalves, E. Abdala, I. Boszczowski, A.S.S. Levin O0065Decrease in healthcare-associated infection methicillin-resistant Staphylococcus aureus bacteraemia using a prevention bundle audit tool with real-time feedback C. Carter* (Miami, United States), K.A. Sposato, M. Jimenez Hamann, L.M. Abbo O0066Pilot clinical trial: testing a diagnostic lozenge for impending urinary catheter blockage R. Heylen* (Bath, United Kingdom), T. Jenkins Saturday, 23 April 2022SCIENTIFIC PROGRAMME68 O0067Bundle of interventions to accomplish 365 days without catheter-associated urinary tract infections (CAUTI) hospital-wide during the COVID-19 pandemic at a community hospital in Miami, FL A. Jimenez* (Miami, United States), K. Sposato, P.A. Anderson, V. Perez, J.V. Caprile, D. Diaz, M. Mann, L.M. Abbo OS01408:30 - 10:30Hall N 2-Hour Oral Session Soft tissue, bone and joint infections: a treatment update ChairsAnne Claude Cremieux (Paris, France) Andrej Trampuz (Berlin, Germany) O0068Community acquired skin and soft tissue infections in people who inject drugs compared to non-injection drug users R. Kivlehan* (Dublin, Ireland), N.R. Power, A. O’donnell, O. Hennigan, P. Mcgettrick, J.S. Lambert, G. Sheehan, A. Cotter, T. Mcginty, D. Morley, E. Muldoon, J. Woo O0069Experience with long-term linezolid use (>28 days) in bone and joint infections: safe and well- tolerated C.M. Veerman* (Nijmegen, Netherlands), D.S.C. Telgt, J.H.M. Goosen, P.J.C. Heesterbeek O0070Epidemiology and management of large joint septic arthritis: evolution over time during an eleven-year period at a referral centre P. Malosso* (Bologna, Italy), S. Tedeschi, E. Zamparini, N. Rossi, M. De Paolis, N. Maria Pia, P. Viale O0071Efficacy and safety of intravenous fosfomycin in patients with PJI: preliminary results from the PROOF study, a prospective multi-centre study S. Karbysheva* (Berlin, Germany), P. Morovic, D. Margaryan, L. Johannsen, A. Trampuz O0072Evaluation of the efficacy of ceftazidime- avibactam alone or in combinations in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis B. Davido* (Garches, France), A.C. Cremieux, A. Cara, I. Vaugier, L. Gatin, L. Noussair, L. Massias, F. Laurent, A. Saleh-Mghir O0073Time-trends in microbiological aetiology and resistance profile in diabetic foot osteomyelitis M. Mancheno-Losa* (Madrid, Spain), O. Robineau, E. Beltrand, D. Joulie, P. Patoz, N. Blondiaux, M. Cazaubiel, J. Lora-Tamayo, E. Senneville O0074Clinical experience of intravenous fosfomycin in the treatment of challenging infections D. Margaryan* (Berlin, Germany), S. Karbysheva, V. Dos Santos, A. Trampuz O0075Dalbavancin for indications other than skin and soft tissue infections: retrospective analysis of a large monocentric cohort S. Coladonato* (Pescara, Italy), F. Trave, E. Mazzotta, S. Ianniruberto, G. Parruti, G. Rapacchiale O0076Who returns to work after vertebral osteomyelitis? N. Jung* (Cologne, Germany), A. Yagdiran, J. Bredow, C. Otto-Lambertz, G. Mousabasha, N. Kernich, C. Weber, P. Eysel, J. Fischer O0077Septic arthritis of the knee: arthroscopy or arthrotomy? A comparative study J. Esteban* (Madrid, Spain), A. Martinez-Ulloa, M. Tovar-Bazaga, S. Gabardo-Calvo, J. Garcia- Cañete, A. Blanco-Garcia, E. Torrecilla-Sadaba, A. Auñon-Rubio ID CM SY01511:00 - 12:00Hall B Symposium Young Investigator Award for Research in CM and ID ChairsJon S. Friedland (London, United Kingdom) Annelies Zinkernagel (Zurich, Switzerland) S007811:00Can artificial intelligence and real-time monitoring support optimised antimicrobial use? Timothy Rawson (London, United Kingdom) S007911:30Epidemiology and clinical management of infections in patients with liver cirrhosis Michele Bartoletti (Bologna, Italy) PH SY01611:00 - 12:00Hall E Symposium COVID-19 beyond the clinic: the importance of public engagement ChairsKatharina Last (Homburg, Germany) Alvaro Pascual Hernandez (Seville, Spain) S008011:00Public engagement in COVID-19: pros and cons from the front line Yazdan Yazdanpanah (Paris, France) S008111:30Science, policy and social media in COVID-19 Isabella Eckerle (Geneva, Switzerland) Co-organised with: ESCMID Scientific Affairs Subcommittee (SAS) CM SY01711:00 - 12:00Hall I Symposium Pathogenic Escherichia coli: the emergence of cross- pathotypes from the genomic continuum ChairsTheresa J. Ochoa (Lima, Peru) Rosangela Tozzoli (Rome, Italy) S008211:00Escherichia coli pathotypes causing paediatric infection in low resource settings Inacio Mandomando (Maputo, Mozambique) Saturday, 23 April 2022FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 202369 S008311:30Redefining enteroaggregative Escherichia coli (EAEC): genomic characterisation of epidemiological EAEC strains Nadia Boisen (Copenhagen, Denmark) ID ME01811:00 - 12:00Hall J Meet-the-Expert Interactive paediatric cases M008411:00Julie Toubiana (Paris, France) M008511:30Susanna Esposito (Parma, Italy) Co-organised with: European Society of Paedriatic Infectious Diseases (ESPID) CM ME01911:00 - 12:00Hall K Meet-the-Expert How to apply Digital PCR in clinical microbiology M008611:00Jim Huggett (Teddington, United Kingdom) M008711:30Keith Jerome (Seattle, United States) OS02011:00 - 12:00Hall C 1-Hour Oral Session Novel insights into herpetic infections ChairsMatthijs Brouwer (Amsterdam, Netherlands) Gülsen Özkaya Sahin (Lund, Sweden) O0088Phenotypes of novel cytomegalovirus UL54 DNA polymerase mutations selected in clinically resistant transplant recipients M. Santos-Bravo* (Barcelona, Spain), N. Plault, M. Bodro, A. Moreno, A.B. Pérez-Jiménez, J. Torre- Cisneros, E. Vidal-Verdú, F. Cofán, C. Rodríguez- Rubio, S. Sánchez-Palomino, S. Alain, M.Á. Marcos O0089Human cytomegalovirus-specific T cell reconstitution and late-onset cytomegalovirus infection in haematopoietic stem cell transplant recipients following letermovir prophylaxis I. Cassaniti* (Pavia, Italy), E. Gabanti, O. Borsani, A.A. Colombo, F. Zavaglio, L. Binaschi, D. Caldera, R. Sciarra, G. Cassinelli, E.P. Alessandrino, P. Bernasconi, V.V. Ferretti, D. Lilleri, F. Baldanti O0090Time to first cytomegalovirus viraemia clearance in transplant recipients with refractory cytomegalovirus infection with or without resistance receiving maribavir versus investigator-assigned therapy: subgroup analyses of a phase III trial S. Alain* (Limoges, France), D. Florescu, D. Kumar, J. Wu, M. Fournier O0091Cytomegalovirus impact in B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy E. Marquez-Algaba* (Barcelona, Spain), B. Pernas, J. Esperalba, C. Carpio, I. Los-Arcos, G. Iacoboni, P. Barba, I. Ruiz-Camps O0092Comparison of viral and host transcriptomic profiles in patients with genital infections caused by herpes simplex viruses 1 and 2 S. Burrel* (Paris, France), D. Boutolleau, G. Gricourt, M. N’debi, V. Demontant, C. Rodriguez OS02111:00 - 12:00Hall F 1-Hour Oral Session Digital health applications for CM/ID ChairsSilvio Daniel Brugger (Zurich, Switzerland) Holger Rohde (Hamburg, Germany) O0093Learning a meaningful latent space representation for patient risk stratification: model development and validation for dengue B. Hernandez* (London, United Kingdom), O. Stiff, D.K. Ming, N.L. Vuong, N.M. Tuan, N.V.V. Chau, H.Q. Chanh, N.M. Nguyet, N.Q. Huy, P.K. Lam, D.T.H. Tam, D.T. Trung, H.T. Trieu, C.P. Simmons, B. Wills, A.H. Holmes, S. Yacoub, P. Georgiou O0094AmPHI-TIPS: risk stratification for pre-hospital patients M.L. Mogensen* (Aalborg, Denmark), L.M. Ward, A.L. Madsen, T.A. Lindskou, E.F. Christensen O0095Performance evaluation of machine-assisted interpretation of Gram stains from positive blood cultures C. Walter* (Heidelberg, Germany), C. Weissert, E. Gizewski, H. Mannsperger, I. Burckhardt, S. Zimmermann, O. Nolte O0096A machine learning approach to dengue diagnosis and the impact of seasonality in patients presenting with an acute febrile illness in Ho Chi Minh city, Vietnam D. Ming* (London, United Kingdom), N.M. Tuan, B. Hernandez, S. Sangkaew, N.L. Vuong, H.Q. Chanh, N.V.V. Chau, C.P. Simmons, B. Wills, P. Georgiou, A.H. Holmes, S. Yacoub O0097Combination of predictive classification algorithms, using automated training techniques and MALDI-TOF MS for capsular serotyping of Streptococcus pneumoniae J. Zintgraff* (Caba, Argentina), F. Rocca, M. Santos, D. Napoli, N. Sanchez Eluchans, C. Lara, M. Prieto Saturday, 23 April 2022Next >